| Financial Year |
March 31 2023 |
| Monetary Funds |
318,908,459.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
6,308,587.88 |
| Accounts Receivable |
398,033,333.86 |
| Advances to Suppliers |
3,123,283.57 |
| Other Receivables |
3,971,931.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
84,249,828.15 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
46,980,805.22 |
| Total Current Assets |
898,859,975.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
77,158,032.79 |
| Under-construction Projects |
83,333,389.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,965,323.26 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
192,448.76 |
| Deferred Income Tax Assets |
9,926,642.11 |
| Other Non-Current Assets |
4,871,059.24 |
| Sub-Total of Non-Current Assets |
232,476,397.21 |
| Total Assets |
1,131,336,372.67 |
| Short-Term Loans |
30,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
86,623,161.44 |
| Accounts Payable |
209,353,460.53 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,931,796.35 |
| Taxes Payable |
2,367,390.63 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,269,710.23 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
960,353.19 |
| Other Current Liabilities |
4,673,928.43 |
| Sub-Total of Current Liabilities |
349,167,058.69 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,839,111.46 |
| Total Liabilities |
383,006,170.15 |
| Paid-In Capital(Or Share Stock) |
136,109,184.00 |
| Capital Surplus |
340,035,510.11 |
| Surplus Reserve |
26,653,131.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
245,532,377.25 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
748,330,202.52 |
| Owner's Equity（Stockholder's Equity） |
748,330,202.52 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,131,336,372.67 |
